Nigel Stallard

23PUBLICATIONS
56CO-AUTHORS
Cancer geneticsInfectious diseasesPredictive and prognostic markersSolid tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 10, 2025
Group-Sequential Designs With an Externally-Driven Change of Primary Endpoint.

Amin Yarahmadi, Lori E Dodd, Peter Horby

|Oct 30, 2024
Statistical methods for clinical trials interrupted by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic: A review.

Joydeep Basu, Nicholas Parsons, Tim Friede

|Sep 25, 2024
Testing for a treatment effect in a selected subgroup.

Nigel Stallard

|Aug 21, 2024
Group sequential designs for clinical trials when the maximum sample size is uncertain.

Amin Yarahmadi, Lori E Dodd, Thomas Jaki

|Sep 02, 2022
Should the two-trial paradigm still be the gold standard in drug assessment?

Stella Jinran Zhan, Cornelia Ursula Kunz, Nigel Stallard

Pageof 4